1 min read
Add as a preferred source on Google

STERIS Raises Adjusted FY2027 EPS Outlook to $11.35-$11.55

Second-quarter revenue rose 9% to $1.6 billion, with constant-currency organic revenue growth of 8%.

Two stainless-steel instrument trays align inside a sterile processing room / TokenPost.ai
Two stainless-steel instrument trays align inside a sterile processing room / TokenPost.ai

STERIS plc raised its fiscal 2027 adjusted diluted earnings-per-share outlook to $11.35-$11.55 while agreeing to acquire Xodus Medical, Inc.

Second-quarter as-reported revenue rose 9% to $1.6 billion. Constant-currency organic revenue grew 8%. STERIS included tariff refunds received so far this fiscal year among the factors behind its revised outlook.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…